Stringent monitoring can decrease mortality of immune checkpoint inhibitor induced cardiotoxicity

Ying Wang, Carolin Ertl, Christina Schmitt, Linda Hammann, Rafaela Kramer, Ulrich Grabmaier, Florian Schöberl, David Anz, Ignazio Piseddu, Giulia Pesch, Julio Vera, Waltraud Froehlich, Ludwig Weckbach, Dirk Tomsitz, Carmen Loquai, Lisa Zimmer, Johanna Mangana, Reinhard Dummer, Ralf Gutzmer, Kai-Christian Klespe, Henner Stege, Frank Meiss, Kai-Martin Thoms, Patrick Terheyden, Paul J. Bröckelmann, Douglas B. Johnson, Lars E. French, Lucie Heinzerling

Open source

DOI
10.3389/fcvm.2024.1408586
Published
2024-06-10
Container
Frontiers in Cardiovascular Medicine
Publisher
Frontiers Media SA
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fcvm.2024.1408586,
  title = {Stringent monitoring can decrease mortality of immune checkpoint inhibitor induced cardiotoxicity},
  author = {Ying Wang and Carolin Ertl and Christina Schmitt and Linda Hammann and Rafaela Kramer and Ulrich Grabmaier and Florian Schöberl and David Anz and Ignazio Piseddu and Giulia Pesch and Julio Vera and Waltraud Froehlich and Ludwig Weckbach and Dirk Tomsitz and Carmen Loquai and Lisa Zimmer and Johanna Mangana and Reinhard Dummer and Ralf Gutzmer and Kai-Christian Klespe and Henner Stege and Frank Meiss and Kai-Martin Thoms and Patrick Terheyden and Paul J. Bröckelmann and Douglas B. Johnson and Lars E. French and Lucie Heinzerling},
  year = {2024},
  journal = {Frontiers in Cardiovascular Medicine},
  doi = {10.3389/fcvm.2024.1408586},
  url = {https://doi.org/10.3389/fcvm.2024.1408586}
}

RIS

TY  - JOUR
TI  - Stringent monitoring can decrease mortality of immune checkpoint inhibitor induced cardiotoxicity
AU  - Ying Wang
AU  - Carolin Ertl
AU  - Christina Schmitt
AU  - Linda Hammann
AU  - Rafaela Kramer
AU  - Ulrich Grabmaier
AU  - Florian Schöberl
AU  - David Anz
AU  - Ignazio Piseddu
AU  - Giulia Pesch
AU  - Julio Vera
AU  - Waltraud Froehlich
AU  - Ludwig Weckbach
AU  - Dirk Tomsitz
AU  - Carmen Loquai
AU  - Lisa Zimmer
AU  - Johanna Mangana
AU  - Reinhard Dummer
AU  - Ralf Gutzmer
AU  - Kai-Christian Klespe
AU  - Henner Stege
AU  - Frank Meiss
AU  - Kai-Martin Thoms
AU  - Patrick Terheyden
AU  - Paul J. Bröckelmann
AU  - Douglas B. Johnson
AU  - Lars E. French
AU  - Lucie Heinzerling
PY  - 2024
JO  - Frontiers in Cardiovascular Medicine
DO  - 10.3389/fcvm.2024.1408586
UR  - https://doi.org/10.3389/fcvm.2024.1408586
ER  - 

APA

Wang, Y., Ertl, C., Schmitt, C., Hammann, L., Kramer, R., Grabmaier, U., Schöberl, F., Anz, D., Piseddu, I., Pesch, G., Vera, J., Froehlich, W., Weckbach, L., Tomsitz, D., Loquai, C., Zimmer, L., Mangana, J., Dummer, R., Gutzmer, R., Klespe, K., Stege, H., Meiss, F., Thoms, K., Terheyden, P., Bröckelmann, P. J., Johnson, D. B., French, L. E., & Heinzerling, L. (2024). Stringent monitoring can decrease mortality of immune checkpoint inhibitor induced cardiotoxicity. Frontiers in Cardiovascular Medicine. https://doi.org/10.3389/fcvm.2024.1408586

Source records